COMMUNIQUÉS West-GlobeNewswire

NeoGenomics Completes Acquisition of Genoptix, Inc.
10/12/2018
FT. MYERS, Fla., Dec. 10, 2018 (GLOBE NEWSWIRE) -- NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, announced today that it has completed the acquisition of the parent [...]
B. Braun’s Innovative Compounding System Installed at Texas Children’s Hospital
10/12/2018
BETHLEHEM, Pa., Dec. 10, 2018 (GLOBE NEWSWIRE) -- B. Braun Medical Inc. successfully installed its new and innovative macro and micro APEX ® Compounding System at Texas Children’s Hospital in Houston, Texas. The [...]
Financial calendar for Zealand Pharma in 2019
10/12/2018
Company announcement – No. 30/2018 Financial calendar for Zealand Pharma in 2019 Copenhagen, December 10, 2018 – Zealand Pharma A/S (“ZEAL”) announces the following dates for the company's planned financial reporting in [...]
CERESPIR INCORPORATED and the NATIONAL NEUROSCIENCE INSTITUTE SINGAPORE Announce Positive Data Showing Beneficial Effects of CERESPIR’s Clinical Stage Compound Itanapraced in a LRRK2 Model of Parkinson’s Disease
10/12/2018
Itanapraced blocks LRRK2 expression and LRRK2-mediated neurotoxicity Itanapraced ready to advance to Phase 2 in Parkinson’s disease patients with and without genetic mutation NEW YORK and SINGAPORE, Dec. 10, 2018 (GLOBE [...]
Editas Medicine Names Cynthia Collins to Board of Directors
10/12/2018
CAMBRIDGE, Mass., Dec. 10, 2018 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, today announced that it has appointed Cynthia Collins to its Board of Directors. Ms. Collins is [...]
Denali Therapeutics Announces First Patient Dosed in Phase 1b Study of DNL201 for Parkinson’s Disease
10/12/2018
Phase 1b study includes Parkinson’s disease patients with and without a genetic LRRK2 mutation SOUTH SAN FRANCISCO, Calif., Dec. 10, 2018 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (NASDAQ: DNLI), a biopharmaceutical [...]
Advantis Corp.’s Pet Division Making Progress Toward Debut
10/12/2018
NEWPORT BEACH, CA, Dec. 10, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – ADVANTIS CORPORATION (OTC PINK: ADVT) announced today that it has entered into negotiations with potential manufacturers of its products for the [...]
MPX Awarded Four Conditional Retail Dispensary Licenses in Nevada
10/12/2018
TORONTO, Dec. 10, 2018 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (“ MPX ” or the “ Company ”) (CSE: MPX; OTC: MPXEF) announced that GreenMart NLV, LLC (“ GreenMart NLV ”), a subsidiary of MPX, has been awarded [...]
RespireRx Pharmaceuticals Inc. Executives Presenting at the International Cannabinoid Derived Pharmaceuticals Summit
10/12/2018
December 11 – 12, 2018 Workshops, December 10, 2018 The Revere Hotel 200 Stuart St., Boston, MA SVP R&D leading workshop on Financial Planning and Commercial Development SVP R&D to present A Translational R& [...]
Novo Nordisk A/S - Share repurchase programme
10/12/2018
Bagsværd, Denmark, 10 December 2018 - On 5 November 2018, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April [...]
Enzymatica AB: Appeal on Enzymatica's cold spray in Germany overruled
10/12/2018
Press release December 10, 2018 Appeal on Enzymatica's cold spray in Germany overruled Enzymatica has been informed that the Frankfurt Higher Regional Court - OLG (Oberlandesgericht) has overruled the appeal on a [...]
Agritek Holdings, Inc. Announces Resignation of CEO, Names New Interim CEO, With Company To Bring On New Advisory Board And Management Consultants Specializing In Cannabis Sector
10/12/2018
LOS ANGELES, CA, Dec. 10, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Agritek Holdings, Inc. (OTC PINK: AGTK) www.AgritekHoldings.com , a fully integrated, active real estate investor for the cannabis sector in the [...]
Eve & Co Receives Expanded Health Canada Licences
10/12/2018
TORONTO, Dec. 10, 2018 (GLOBE NEWSWIRE) -- Eve & Co Incorporated (TSX-V: EVE; OTCQB: EEVVF) (“Eve & Co” or the “Company”) is pleased to announce that as of December 7, 2018, Health Canada authorized Natural [...]
Abattis to Display Products and Services at O’Cannabiz Conference on December 10-11th, 2018
10/12/2018
VANCOUVER, British Columbia, Dec. 10, 2018 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp (the “ Company ” or “ Abattis ”) (CSE:ATT) (OTC:ATTBF) is pleased to announce that the Company will be displaying a booth at the O [...]
Achaogen Announces FDA Clearance and Launch of the Thermo Scientific QMS Plazomicin Immunoassay
10/12/2018
Thermo Fisher Scientific and Achaogen jointly develop new assay to enable Therapeutic Drug Management SOUTH SAN FRANCISCO, Calif., Dec. 10, 2018 (GLOBE NEWSWIRE) -- Achaogen, Inc. (NASDAQ: AKAO), a biopharmaceutical [...]
Allscripts to sell its interests in Netsmart
10/12/2018
CHICAGO, Dec. 10, 2018 (GLOBE NEWSWIRE) -- Allscripts (NASDAQ: MDRX), a global leader in healthcare information technology, today announced that it has signed a definitive agreement to sell its interests in Netsmart [...]
Sientra Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
10/12/2018
SANTA BARBARA, Calif., Dec. 10, 2018 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN) (“Sientra” or the “Company”), a medical aesthetics company, today announced that on December 5, 2018, the Compensation Committee of [...]
Introducing The Diamond CBD Referral Program Give $25 and Receive $25 by Referring a Friend
10/12/2018
FT LAUDERDALE, Fla., Dec. 10, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE-- Diamond CBD, Inc., wholly owned subsidiary of PotNetwork Holdings, Inc. (OTC Pink: POTN ) is pleased to announce the successful introduction to [...]
Nkarta Therapeutics Announces Appointment of Matthew Plunkett, Ph.D., as Chief Financial Officer
10/12/2018
SOUTH SAN FRANCISCO, Calif., Dec. 10, 2018 (GLOBE NEWSWIRE) -- Nkarta Therapeutics, a privately-held cell therapy company developing engineered Natural Killer (NK) immune cells to fight cancer, today announced that [...]

Pages